Strata Skin Sciences, Inc.
SSKN
$2.59
-$0.03-1.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.50M | -2.12M | -99.00K | -3.37M | -3.79M |
| Total Depreciation and Amortization | 1.31M | 1.32M | 1.33M | 1.34M | 1.37M |
| Total Amortization of Deferred Charges | 39.00K | 39.00K | 39.00K | 31.00K | 28.00K |
| Total Other Non-Cash Items | 3.69M | -25.00K | 115.00K | 350.00K | 2.57M |
| Change in Net Operating Assets | 156.00K | 486.00K | -793.00K | 839.00K | 1.20M |
| Cash from Operations | 703.00K | -302.00K | 591.00K | -804.00K | 1.37M |
| Capital Expenditure | -504.00K | -62.00K | -345.00K | -725.00K | -1.72M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -504.00K | -62.00K | -345.00K | -725.00K | -1.72M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 1.94M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -18.00K | 0.00 |
| Cash from Financing | 0.00 | 1.94M | 0.00 | -18.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 199.00K | 1.58M | 246.00K | -1.55M | -347.00K |